Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.nut.2020.110948 http://scihub22266oqcxt.onion/10.1016/j.nut.2020.110948 C7381407!7381407 !32911430     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32911430 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Nutrition 2020 ; 79-80 (?): 110948 Nephropedia Template TP {{tp|p=32911430 |t=2020. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? |pdf=|usr=}}{{32911430 }} gab.com Text Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19 JO: Nutrition http://www.kidney.de/pget.php?&tw=1&pmid=32911430 #FOAvip Severe acute respiratory syndrome coronavirus 2 causes the potentially fatal coronavirus disease 2019 (COVID-19). Already during the outbreak of the severe acute respiratory syndrome coronavirus 1, the use of vitamin C was suggested. Many patients with severe COVID-19 have elevated levels of the mediators interleukin-6 and endothelin-1. These mediators may explain the age dependence of COVID-19 pneumonia, the preponderance of male and obese or hypertensive patients, as well as of persons of color and smokers. There is clear evidence that vitamin C in high doses can reduce these mediators. Vitamin C is cheap and safe. Hence, using a relatively low dose of vitamin C as prophylaxis, and in cases of severe COVID-19, an (intravenous) high-dose regimen may be beneficial. Ongoing clinical trials are expected to provide more definitive evidence. Twit Text FOAVip Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19 ????Nutrition http://www.kidney.de/pget.php?&tw=1&pmid=32911430 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32911430 #FOAvip English Wikipedia <ref>{{Cite pmid|32911430 }}</ref> Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? #MMPMID32911430 Feyaerts AF ; Luyten W Nutrition 2020[Nov]; 79-80 (?): 110948 PMID32911430 show ga Severe acute respiratory syndrome coronavirus 2 causes the potentially fatal coronavirus disease 2019 (COVID-19). Already during the outbreak of the severe acute respiratory syndrome coronavirus 1, the use of vitamin C was suggested. Many patients with severe COVID-19 have elevated levels of the mediators interleukin-6 and endothelin-1. These mediators may explain the age dependence of COVID-19 pneumonia, the preponderance of male and obese or hypertensive patients, as well as of persons of color and smokers. There is clear evidence that vitamin C in high doses can reduce these mediators. Vitamin C is cheap and safe. Hence, using a relatively low dose of vitamin C as prophylaxis, and in cases of severe COVID-19, an (intravenous) high-dose regimen may be beneficial. Ongoing clinical trials are expected to provide more definitive evidence. |*COVID-19 Drug Treatment [MESH] |Animals [MESH] |Ascorbic Acid/pharmacology/*therapeutic use [MESH] |COVID-19/*prevention & control [MESH] |Coronavirus [MESH] |Female [MESH] |Humans [MESH] |Interleukin-6/metabolism [MESH] |Male [MESH] |Pandemics [MESH] |SARS-CoV-2 [MESH]Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19(epmc).pdf DeepDyve Pubget Overpricing